Intellipharmaceutics International

Intellipharmaceutics International is engaged in the development of controlled-release and targeted pharmaceutical products. 

They believe that their Hypermatrix technology is a novel and robust controlled-release drug delivery platform. This unique technology allows them to provide life-cycle management or new chemical entity delivery system solutions for virtually any small molecule. The flexibility of this technology allows them to quickly develop complex drug delivery solutions.